Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Taryn Audrey Liu has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Afua Tetteh

    Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA 94304, USA

    2 shared publications
  • Antonia Zoe Quake

    Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA 94304, USA

    2 shared publications
  • Kari Christine Nadeau

    Stanford University School of Medicine, Palo Alto, USA

    2 shared publications
  • Katherine G. Jackson

    Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA 94304, USA

    2 shared publications
  • Margaret Woch

    Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA 94304, USA

    2 shared publications
  • Rachel D’Souza

    Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA 94304, USA

    2 shared publications

Latest Publications

  • Open Access

    Rapid and quantitative functional interrogation of human enhancer variant activity in live mice

    by Ethan W. Hollingsworth, Taryn A. Liu, Joshua A. Alcantara, Cindy X. Chen, Sandra H. Jacinto, Evgeny Z. Kvon

    Functional analysis of non-coding variants associated with congenital disorders remains challenging due to the lack of efficient in vivo models. Here we introduce dual-enSERT, a robust Cas9-based two-color fluorescent reporter system which enables rapid, quantitative comparison of enhancer allele activities in live mice in less than two weeks. We use this technology to examine and measure the gain- and loss-of-function effects of enhancer variants previously linked to limb polydactyly, autism spectrum disorder, and craniofacial malformation. By combining dual-enSERT with single-cell transcriptomics, we characterise gene expression in cells where the enhancer is normally and ectopically active, revealing candidate pathways that may lead to enhancer misregulation. Finally, we demonstrate the widespread utility of dual-enSERT by testing the effects of fifteen previously uncharacterised rare and common non-coding variants linked to neurodevelopmental disorders. In doing so we identify variants that reproducibly alter the in vivo activity of OTX2 and MIR9-2 brain enhancers, implicating them in autism. Dual-enSERT thus allows researchers to go from identifying candidate enhancer variants to analysis of comparative enhancer activity in live embryos in under two weeks.


  • Open Access

    Correction: Quake et al. Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study. Nutrients 2022, 14, 737

    by Antonia Zoe Quake, Taryn Audrey Liu, Rachel D’Souza, Katherine G. Jackson, Margaret Woch, Afua Tetteh, Vanitha Sampath, Kari C. Nadeau, Sayantani Sindher, R. Sharon Chinthrajah, et al.


  • Open Access

    Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study

    by Antonia Zoe Quake, Taryn Audrey Liu, Rachel D’souza, Katherine G. Jackson, Margaret Woch, Afua Tetteh, Vanitha Sampath, Kari C. Nadeau, Sayantani Sindher, R. Sharon Chinthrajah, et al.

    The incidence and prevalence of food allergy (FA) is increasing. While several studies have established the safety and efficacy of early introduction of single allergens in infants for the prevention of FA, the exact dose, frequency, and number of allergens that can be safely introduced to infants, particularly in those at high or low risk of atopy, are still unclear. This 1-year pilot study evaluated the safety of the early introduction of single foods (milk, egg, or peanut) vs. two foods (milk/egg, egg/peanut, milk/peanut) vs. multiple foods (milk/egg/peanut/cashew/almond/shrimp/walnut/wheat/salmon/hazelnut at low, medium, or high doses) vs. no early introduction in 180 infants between 4–6 months of age. At the end of the study, they were evaluated for plasma biomarkers associated with food reactivity via standardized blood tests. Two to four years after the start of the study, participants were evaluated by standardized food challenges. The serving sizes for the single, double, and low dose mixtures were 300 mg total protein per day. The serving sizes for the medium and high dose mixtures were 900 mg and 3000 mg total protein, respectively. Equal parts of each protein were used for double or mixture foods. All infants were breastfed until at least six months of age. The results demonstrate that infants at either high or low risk for atopy were able to tolerate the early introduction of multiple allergenic foods with no increases in any safety issues, including eczema, FA, or food protein induced enterocolitis. The mixtures of foods at either low, medium, or high doses demonstrated trends for improvement in food challenge reactivity and plasma biomarkers compared to single and double food introductions. The results of this study suggest that the early introduction of foods, particularly simultaneous mixtures of many allergenic foods, may be safe and efficacious for preventing FA and can occur safely. These results need to be confirmed by larger randomized controlled studies.


  • Open Access

    Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy

    by A. Zoe Quake, Taryn Audrey Liu, Rachel D’souza, Katherine G Jackson, Margie Woch, Afua Tetteh, Vanitha Sampath, Kari C Nadeau, Sayantani Sindher, R. Sharon Chinthrajah, et al.

    The incidence and prevalence of food allergy (FA) are increasing. While several studies have established the safety and efficacy of early introduction of single allergens in infants for the prevention of FA, the exact dose, frequency, and number of allergens that can be safely introduced to infants particularly in those at high or low risk of atopy are still unclear. This 1-year study evaluated the safety of early introduction of single foods (milk, egg, or peanut), vs. two foods (milk/egg, egg/peanut, milk/peanut), vs. multiple foods (milk/egg/peanut/cashew/almond/shrimp/walnut/wheat/fish/soy at low, medium, or high doses) vs no early introduction in infants between 4-6 months of age. At the end of the study, they were evaluated for plasma biomarkers associated with food reactivity with standardized blood tests. Two to four years after the start of the study, participants were evaluated by standardized food challenges. The serving sizes for the single, double, and low dose mixtures were 300 mg total protein per day. The serving sizes for the medium and high dose mixture was 900 mg and 3000 mg total protein, respectively. Equal parts of each protein were used for double or mixture foods. All infants were breastfed until at least 6 months of age. Results demonstrate that infants at either high or low risk for atopy were able to tolerate early introduction of multiple allergenic foods with no increases in any safety issues, including eczema, FA, or food protein induced enterocolitis. The mixtures of foods at either low, medium, or high doses demonstrated trends for improvement in food challenge reactivity and plasma biomarkers compared to single and double food introductions. The results of this study suggest that early introduction of foods, particularly simultaneous mixtures of many allergenic foods is efficacious for preventing FA and can occur safely.

  • A052 EXPLORATORY STUDIES ON HUMAN GI-RESIDENT GAMMA DELTA T CELLS BEFORE AND AFTER PEANUT ORAL IMMUNOTHERAPY

    by T. Liu, W. Zhang, G. Dhondalay, N. Kambham, M. Manohar, S. Chinthrajah, K. Nadeau